Stay updated on Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.

Latest updates to the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a software update or patch applied to the ClinicalTrials.gov page rendering; it does not change the study details, locations, or eligibility criteria.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page footer revision has been updated from v3.5.2 to v3.5.3, reflecting a minor website version change without altering the displayed trial information.SummaryDifference0.1%

- Check44 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check65 days agoChange DetectedStandardized the disease name hyphenation to 'Alpha-1 antitrypsin deficiency'.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.